Suppression of LPS-Induced TNF-α Production in Macrophages by cAMP Is Mediated by PKA-AKAP95-p105
Estelle A. Wall,Joelle R. Zavzavadjian,Mi-Sook Chang,Baljinder S. Randhawa,Xiaocui Zhu,R. Hsueh,Jamie Liu,A. Driver,X. R. Bao,P. Sternweis,M. Simon,I. Fraser
DOI: https://doi.org/10.1126/scisignal.2000202
IF: 9.517
2009-06-16
Science Signaling
Abstract:Distinct anchoring proteins enable cAMP signaling to selectively modulate macrophage responses to pathogens. Specific Scaffolds Macrophages are innate immune cells that mediate early responses to infection by sensing microbial products through Toll-like receptors (TLRs) and producing proinflammatory compounds, such as tumor necrosis factor–α (TNF-α). A modulator of this proinflammatory response is prostaglandin E2 (PGE2), which activates G protein–coupled receptors that couple to Gαs, leading to the production of cyclic adenosine monophosphate (cAMP). As well as inhibiting the production of TNF-α by macrophages in response to the TLR4 agonist LPS, PGE2 and cAMP also stimulate the production of the anti-inflammatory cytokines interleukin-10 (IL-10) and granulocyte colony-stimulating factor (G-CSF) (see the Perspective by Peters-Golden). Wall et al. found that the pleiotropic effects of PGE2 and cAMP on LPS-stimulated cytokine production depended on the fate of cAMP-dependent protein kinase (PKA). Selective binding of activated PKA to different scaffold proteins known as A kinase–anchoring proteins (AKAPs) resulted in differential effects on the expression of genes encoding cytokines. In particular, cAMP-dependent inhibition of TNF-α expression involved phosphorylation of the NF-κB transcription factor p105 by PKA bound to AKAP95, which inhibited the nuclear translocation of the transcription factor, whereas the effect of PKA on the enhancement of G-CSF expression was mediated by another AKAP; the effect of PKA on IL-10 expression was AKAP-independent. Together, these data uncover crosstalk between TLR4 and cAMP signaling pathways that depend on the differential localization of PKA by different scaffold proteins, which could have implications for anti-inflammatory therapies. The activation of macrophages through Toll-like receptor (TLR) pathways leads to the production of a broad array of cytokines and mediators that coordinate the immune response. The inflammatory potential of this response can be reduced by compounds, such as prostaglandin E2, that induce the production of cyclic adenosine monophosphate (cAMP). Through experiments with cAMP analogs and multigene RNA interference (RNAi), we showed that key anti-inflammatory effects of cAMP were mediated specifically by cAMP-dependent protein kinase (PKA). Selective inhibitors of PKA anchoring, time-lapse microscopy, and RNAi screening suggested that differential mechanisms of PKA action existed. We showed a specific role for A kinase–anchoring protein 95 in suppressing the expression of the gene encoding tumor necrosis factor–α, which involved phosphorylation of p105 (also known as Nfkb1) by PKA at a site adjacent to the region targeted by inhibitor of nuclear factor κB kinases. These data suggest that crosstalk between the TLR4 and cAMP pathways in macrophages can be coordinated through PKA-dependent scaffolds that localize specific pools of the kinase to distinct substrates.